Literature DB >> 32035797

Cushing's syndrome: Treatment and new therapeutic approaches.

Amandine Ferriere1, Antoine Tabarin2.   

Abstract

Overt Cushing's syndrome is a severe condition responsible for multiple comorbidities and increased mortality. Effective treatment is essential to reduce mortality, improve comorbidities and long-term quality of life. Surgical resection of the causal lesion(s) is generally the first-line and most effective treatment to normalize cortisol secretion. Adjunctive symptomatic treatments of co-morbidities are often necessary both during the active phase of the disease and for persisting co-morbidities after cessation of hypercortisolism. Second-line treatments include various pharmacological treatments, bilateral adrenalectomy, and radiotherapy of corticotroph tumors. The choice of these treatments is complex, must be performed in a multidisciplinary expert team to be individualized for each patient, and use a shared decision-making approach.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cushing's syndrome; anticortisolic drugs; bilateral adrenalectomy; intense hypercortisolism; pituitary radiotherapy; surgery

Year:  2020        PMID: 32035797     DOI: 10.1016/j.beem.2020.101381

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  7 in total

1.  PI3K inhibition by BKM120 results in anti-proliferative effects on corticotroph tumor cells.

Authors:  H A Oliveira; A C Bueno; R S Pugliesi; R M P da Silva Júnior; M de Castro; C S Martins
Journal:  J Endocrinol Invest       Date:  2022-01-06       Impact factor: 4.256

Review 2.  Cushing's syndrome: a combined treatment with etomidate and osilodrostat in severe life-threatening hypercortisolemia.

Authors:  Lukasz Dzialach; Joanna Sobolewska; Wioleta Respondek; Agnieszka Wojciechowska-Luzniak; Przemyslaw Witek
Journal:  Hormones (Athens)       Date:  2022-09-21       Impact factor: 3.419

3.  Acute pancreatitis associated with Cushing syndrome - A case report and literature review.

Authors:  M Bouali; S Kabura; A El Bakouri; K El Hattabi; F Z Bensardi; A Fadil
Journal:  Ann Med Surg (Lond)       Date:  2021-03-29

Review 4.  Management and Medical Therapy of Mild Hypercortisolism.

Authors:  Vittoria Favero; Arianna Cremaschi; Alberto Falchetti; Agostino Gaudio; Luigi Gennari; Alfredo Scillitani; Fabio Vescini; Valentina Morelli; Carmen Aresta; Iacopo Chiodini
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

5.  Simultaneous pituitary and adrenal adenomas in a patient with non ACTH dependent Cushing syndrome; a case report with literature review.

Authors:  Shaho F Ahmed; Rawa Bapir; Fattah H Fattah; Aras Gh Mahmood; Rawezh Q Salih; Abdulwahid M Salih; Soran H Tahir; Fahmi H Kakamad
Journal:  Int J Surg Case Rep       Date:  2022-04-05

Review 6.  Very Low-Calorie Ketogenic Diet: A Potential Application in the Treatment of Hypercortisolism Comorbidities.

Authors:  Valentina Guarnotta; Fabrizio Emanuele; Roberta Amodei; Carla Giordano
Journal:  Nutrients       Date:  2022-06-09       Impact factor: 6.706

7.  Update in Cushing disease: What the neurosurgeon has to KNOW, on behalf of the EANS skull base section.

Authors:  Sayoa Eulate-Beramendi; Ainhoa Casajús; Lola Ollero; Lynnette K Niemann; Juan Carlos Fernández-Miranda; Michaël Bruneau; Moncef Berhouma; Luigi Maria Cavallo; Jan Frederick Cornelius; Roy T Daniel; Sebastien Froelich; Emmanuel Jouanneau; Ekkehard Kasper; Diego Mazzatenta; Torstein R Meling; Mahmoud Messerer; Henry W S Schroeder; Marcos Tatagiba; Massimiliano Visocchi; Eduard H Voormolen; Idoya Zazpe
Journal:  Brain Spine       Date:  2022-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.